Dai Lu

1.1k total citations
42 papers, 850 citations indexed

About

Dai Lu is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Dai Lu has authored 42 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmacology, 23 papers in Cellular and Molecular Neuroscience and 17 papers in Molecular Biology. Recurrent topics in Dai Lu's work include Cannabis and Cannabinoid Research (29 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Dai Lu is often cited by papers focused on Cannabis and Cannabinoid Research (29 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Dai Lu collaborates with scholars based in United States, Japan and China. Dai Lu's co-authors include Debra A. Kendall, Alexandros Makriyannis, Srikanth Kolluru, Kwang H. Ahn, Aron H. Lichtman, Hamed I. Ali, R. Duclos, Xiao Yu Tian, Zhixing Wu and Atmaram D. Khanolkar and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Dai Lu

40 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dai Lu United States 19 561 406 312 108 84 42 850
Paolo Lazzari Italy 18 385 0.7× 228 0.6× 267 0.9× 232 2.1× 54 0.6× 43 847
Teija Parkkari Finland 17 293 0.5× 203 0.5× 351 1.1× 93 0.9× 36 0.4× 32 666
Marc P. Baggelaar Netherlands 16 459 0.8× 160 0.4× 281 0.9× 129 1.2× 56 0.7× 29 815
Silvano Sanchini United States 9 408 0.7× 144 0.4× 148 0.5× 73 0.7× 44 0.5× 10 545
Marianna Nalli Italy 21 304 0.5× 158 0.4× 375 1.2× 238 2.2× 70 0.8× 52 1.1k
Riku Niemi Finland 13 371 0.7× 174 0.4× 173 0.6× 116 1.1× 45 0.5× 23 702
David K. O’Dell United States 13 285 0.5× 105 0.3× 286 0.9× 134 1.2× 62 0.7× 15 699
Roberta Ranieri Italy 11 433 0.8× 101 0.2× 212 0.7× 36 0.3× 108 1.3× 18 794
Katherine A. Scott United Kingdom 13 300 0.5× 81 0.2× 185 0.6× 114 1.1× 80 1.0× 26 596
Thuy Nguyen United States 13 247 0.4× 236 0.6× 240 0.8× 74 0.7× 22 0.3× 28 485

Countries citing papers authored by Dai Lu

Since Specialization
Citations

This map shows the geographic impact of Dai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Lu more than expected).

Fields of papers citing papers by Dai Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Lu. The network helps show where Dai Lu may publish in the future.

Co-authorship network of co-authors of Dai Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Dai Lu. A scholar is included among the top collaborators of Dai Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dai Lu. Dai Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palakurthi, Sushesh Srivatsa, et al.. (2025). Evaluating critical quality attributes and novel drug release testing of difluprednate nanoemulsions. International Journal of Pharmaceutics. 674. 125431–125431.
2.
3.
Palakurthi, Sushesh Srivatsa, et al.. (2023). Development of optimal in vitro release and permeation testing method for rectal suppositories. International Journal of Pharmaceutics. 640. 123042–123042. 4 indexed citations
4.
Mustafa, Mohammed Ahmed, Justin L. Poklis, Joseph H. Porter, et al.. (2023). Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm. Cannabis and Cannabinoid Research. 9(2). 581–590. 3 indexed citations
5.
Yu, Yang, Yanling Zhao, Zhongcheng Shi, et al.. (2022). ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers. 14(22). 5534–5534. 9 indexed citations
6.
Khuroo, Tahir, Eman M. Mohamed, Sathish Dharani, et al.. (2022). In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery. Journal of Pharmaceutical Sciences. 111(8). 2312–2321. 4 indexed citations
7.
Khuroo, Tahir, Sathish Dharani, Eman M. Mohamed, et al.. (2021). Ultra-long acting prodrug of dolutegravir and delivery system – Physicochemical, pharmacokinetic and formulation characterizations. International Journal of Pharmaceutics. 607. 120889–120889. 11 indexed citations
8.
Mustafa, Mohammed Ahmed, Giulia Donvito, Austin D. Swafford, et al.. (2019). In vivo evaluation of the CB1 allosteric modulator LDK1258 reveals CB1-receptor independent behavioral effects. Pharmacology Biochemistry and Behavior. 190. 172840–172840. 7 indexed citations
9.
Yudowski, Guillermo A., et al.. (2018). Pyrimidinyl Biphenylureas Act as Allosteric Modulators to Activate Cannabinoid Receptor 1 and Initiate β-Arrestin–Dependent Responses. Molecular Pharmacology. 95(1). 1–10. 13 indexed citations
10.
Wei, Han‐Xun, Dai Lu, Jing Zhang, et al.. (2016). Part 2. Notch-sparing γ-secretase inhibitors: The study of novel γ-amino naphthyl alcohols. Bioorganic & Medicinal Chemistry Letters. 26(9). 2133–2137. 5 indexed citations
11.
Lu, Dai, Han‐Xun Wei, Jing Zhang, et al.. (2016). Part 1: Notch-sparing γ-secretase inhibitors: The identification of novel naphthyl and benzofuranyl amide analogs. Bioorganic & Medicinal Chemistry Letters. 26(9). 2129–2132. 2 indexed citations
12.
Zhang, Jing, Dai Lu, Han‐Xun Wei, et al.. (2016). Part 3: Notch-sparing γ-secretase inhibitors: SAR studies of 2-substituted aminopyridopyrimidinones. Bioorganic & Medicinal Chemistry Letters. 26(9). 2138–2141. 3 indexed citations
13.
Vangara, Kiran Kumar, Hamed I. Ali, Dai Lu, et al.. (2014). SN-38-Cyclodextrin Complexation and Its Influence on the Solubility, Stability, and In Vitro Anticancer Activity Against Ovarian Cancer. AAPS PharmSciTech. 15(2). 472–482. 32 indexed citations
14.
Mahmoud, Mariam M., Teresa Olszewska, Hui Liu, et al.. (2014). (4-(Bis(4-Fluorophenyl)Methyl)Piperazin-1-yl)(Cyclohexyl)Methanone Hydrochloride (LDK1229): A New Cannabinoid CB1 Receptor Inverse Agonist from the Class of Benzhydryl Piperazine Analogs. Molecular Pharmacology. 87(2). 197–206. 3 indexed citations
15.
Duclos, R., Dai Lu, Zhixiong Guo, & Alexandros Makriyannis. (2008). Synthesis and characterization of 2-substituted bornane pharmacophores for novel cannabinergic ligands. Tetrahedron Letters. 49(39). 5587–5589. 17 indexed citations
16.
Khanolkar, Atmaram D., Dai Lu, Mohab Ibrahim, et al.. (2007). Cannabilactones: A Novel Class of CB2 Selective Agonists with Peripheral Analgesic Activity. Journal of Medicinal Chemistry. 50(26). 6493–6500. 76 indexed citations
17.
Lu, Dai, Kiran Vemuri, R. Duclos, Bentham Science Publisher Bentham Science Publisher, & Alexandros Makriyannis. (2006). The Cannabinergic System as a Target for Anti-inflammatory Therapies. Current Topics in Medicinal Chemistry. 6(13). 1401–1426. 20 indexed citations
18.
McLaughlin, Peter, Carrie M. Brown, Ganesh A. Thakur, et al.. (2005). The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats. Behavioural Pharmacology. 16(5-6). 477–486. 12 indexed citations
19.
Jin, Wenzhen, A. M. Zvonok, Dai Lu, et al.. (2004). Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist. British Journal of Pharmacology. 142(3). 495–500. 85 indexed citations
20.
Khanolkar, Atmaram D., Dai Lu, Pusheng Fan, Xiao Yu Tian, & Alexandros Makriyannis. (1999). Novel conformationally restricted tetracyclic analogs of Δ8-tetrahydrocannabinol. Bioorganic & Medicinal Chemistry Letters. 9(15). 2119–2124. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Lazzari Breakdown of academic impact, for papers by Teija Parkkari Breakdown of academic impact, for papers by Marc P. Baggelaar Breakdown of academic impact, for papers by Silvano Sanchini Breakdown of academic impact, for papers by Marianna Nalli Breakdown of academic impact, for papers by Riku Niemi Breakdown of academic impact, for papers by David K. O’Dell Breakdown of academic impact, for papers by Roberta Ranieri Breakdown of academic impact, for papers by Katherine A. Scott Breakdown of academic impact, for papers by Thuy Nguyen
Rankless by CCL
2026